rosiglitazone has been researched along with Adenovirus Infections, Human in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bo, X; Fu, X; He, S; Qi, D; Wang, S; Wang, X; Wang, Z; Yang, J; Zhou, Z | 1 |
1 other study(ies) available for rosiglitazone and Adenovirus Infections, Human
| Article | Year |
|---|---|
LINCS dataset-based repositioning of rosiglitazone as a potential anti-human adenovirus drug.
Topics: A549 Cells; Adenovirus Infections, Human; Adenoviruses, Human; Algorithms; Animals; Antiviral Agents; Databases, Pharmaceutical; Drug Repositioning; Epithelial Cells; Female; Humans; Immunocompromised Host; Mice; Mice, SCID; Rosiglitazone; Virus Replication | 2020 |